Skip to main content

Table 4 Comparison of the PET/CT results of patients with and without previous ADT

From: Sensitivity and specificity of PET/CT regarding the detection of lymph node metastases in prostate cancer recurrence

  With hormonal therapy (N = 24) Without hormonal therapy (N = 25)
True-positive 11/24 (45.8%) 11/25 (44.0%)
False-positive 10/24 (41.7%) 10/25 (40.0%)
True-negative 1/24 (4.2%) 1/25 (4.0%)
False-negative 2/24 (8.3%) 3/25 (12.0%)
Specificity (9.1%) (9.1%)
Sensitivity (84.6%) (78.6%)